A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC
- Status
- RECRUITING
- Phase
- PHASE2
HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.
- Status
- RECRUITING
- Phase
- N/A
Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy
- Status
- COMPLETED
- Phase
- NA
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2